Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07195123 · ClinicalTrials.gov registry record · NA
Evaluation of the SMART IBD App in Pediatric IBD
A NA study of Ulcerative Colitis (UC) and Inflammatory Bowel Disease (IBD), sponsored by Children's Hospital Medical Center, Cincinnati.
- Recruiting
- Registry status
- NA
- Development phase
- 70
- Enrollment target
- 1
- Study location
NCT07195123 is a NA study of Ulcerative Colitis (UC) and Inflammatory Bowel Disease (IBD) that is actively recruiting participants, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 70 participants, below the 761-participant average among 17 other Ulcerative Colitis (UC) trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state.
The verdict
NCT07195123, a NA study of Ulcerative Colitis (UC) and Inflammatory Bowel Disease (IBD), is actively recruiting participants, sponsored by Children's Hospital Medical Center, Cincinnati.
- RECRUITING
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this trial is to test whether a smartphone app, SMART-IBD, is effective in improving medication adherence and self-management skills in adolescents with IBD. The investigators will conduct a randomized control trial to compare 35 youth (ages 13-17) with IBD using an app that contains daily symptom diaries, education content, medication reminders, as well as monthly engagement challenges to 35 youth in an attention control group that will complete daily diaries. The length of the intervention will include one month of baseline symptom and adherence collection, a baseline assessment, 5 months of intervention, and a post-treatment assessment.
Conditions Studied
Interventions
- BEHAVIORAL SMART-IBD
Study Locations (1)
Ohio
- Cincinnati Children's Hospital Medical Center - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2025-10-23 |
| Est. Completion | 2027-08-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07195123
The ClinicalTrials.gov registry entry for NCT07195123 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 761-participant average among 17 other Ulcerative Colitis (UC) trials with a reported enrollment target (91% lower). The listed sponsor is Children's Hospital Medical Center, Cincinnati, which has 571 total studies on file at ClinicalTrials.gov.
The record links to 6 conditions, with Ulcerative Colitis (UC) appearing as the primary indexed condition, and to 1 intervention - of which SMART-IBD is the first listed.
NCT07195123 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT07195123 about?
NCT07195123 is a clinical study titled "Evaluation of the SMART IBD App in Pediatric IBD". The objective of this trial is to test whether a smartphone app, SMART-IBD, is effective in improving medication adherence and self-management skills in adolescents with IBD. The investigators will conduct a randomized control trial to compare 35 youth (ages 13-17) with IBD using an app that contain...
What is the current status of trial NCT07195123?
This trial is currently recruiting. It is a NA study. The enrollment target is 70 participants. The study started on 2025-10-23. Estimated completion is 2027-08-31.
What conditions does trial NCT07195123 study?
This clinical trial studies the following conditions: Ulcerative Colitis (UC), Inflammatory Bowel Disease (IBD), Indeterminate Colitis, Crohn Disease (CD), IBD.
What interventions are being tested in trial NCT07195123?
The interventions under investigation include: SMART-IBD (BEHAVIORAL).
Who is sponsoring clinical trial NCT07195123?
This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07195123 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ulcerative Colitis (UC)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
STOP-UC: De-escalation of Therapy in Patients With Ulcerative Colitis With Histological Remission
RECRUITING · NA
-
Use of Psychologist-administered Cognitive Behavioral Therapy (CBT) or Self-administered CBT for the Treatment of Anxiety and/or Depression in Inflammatory Bowel Disease (IBD)
RECRUITING · NA
-
Supplementation of Vitamin D3 in Patients With Inflammatory Bowel Diseases and Hypovitaminosis D
COMPLETED · NA
-
Zymfentra (Infliximab-dyyb) REal World Cohort STudy
RECRUITING
-
Selenium Supplementation in Moderate-Severely Active Ulcerative Colitis Patients Treated With Advanced Therapies
RECRUITING · Phase 2
-
Evaluate the Safety, Tolerability, PK and PD of SAD of Intravenously Adminsterted ALTB-268 in Healthy Participants
RECRUITING · Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.